← FDA DRUG APPROVALS

FDA ANDA · ANDA074460

PIROXICAM

Sponsor: WATSON LABS

APPLICATION
ANDA074460
TYPE
ANDA
ORIGINAL APPROVAL
1995-09-29
LATEST ACTION
2001-04-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PIROXICAMDiscontinued
PIROXICAM 10MG · CAPSULE · ORAL
PIROXICAMDiscontinued
PIROXICAM 20MG · CAPSULE · ORAL

Approval history

2001-04-12Manufacturing (CMC) · Supplement 7AP
2000-03-21Manufacturing (CMC) · Supplement 5AP
1997-07-08Manufacturing (CMC) · Supplement 3AP
1997-06-16Manufacturing (CMC) · Supplement 2AP
1997-06-16Manufacturing (CMC) · Supplement 1AP
1995-09-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →